PPT-Do We Have Enough TAVR Centers?

A Heart Team Perspective Interventional cardiology Megan Coylewright MD MPH FSCAI DartmouthHitchcock Heart and Vascular Center Cardiac surgery Melissa Levack MD Vanderbilt University Medical Center. Centers typically have staffed activities such as music and exercise programs and discussion groups Why use an adult day center One reason to use an adult day center is to give yourself a break from caregiving While your loved one is at a center you By Gabe Siegel. Short Anecdote . Example: US Congressman Bobby Rush’s son was shot and killed on the same block as a Hospital, yet he was driven 10.3 miles to the nearest trauma center. . State of Emergency Medicine. Important Considerations . as TAVR Moves to . Lower-Risk Patients. Benjamin Z Galper MD MPH. Brigham & Women’s Hospital Boston MA. Consequences of Stroke. Mortality. – TAVR patients suffering a VARC-2 disabling stroke have significantly higher mortality rates compared to patients without stroke. 1-year mortality of 67% vs. 12% and 2-year mortality of 83% vs. 20%.. Professor & Vice-Chairman Department of Neurosurgery. Director Neurosurgical Stroke Service, . Kaleida. Health. Chief Medical Officer, Jacobs Institute. Presenting endorsed statement from. American Association of Neurological Surgeons (AANS). Program Goals. Thromboembolic Risk Associated With TAVR. Timing of Stroke and Bleeding Post TAVR. Stroke After TAVR -- Pathophysiology. TAVR and AF Background. Leaflet Thrombosis in Bioprosthetic Aortic Valves: Clinical Outcomes . Overview of Anticoagulation in . Interventional Cardiology. Rivaroxaban in Patients With Recent ACS:. ATLAS ACS 2-TIMI 51. Apixaban After ACS: APPRAISE-2. How Do You Treat Complex Patients?. ACC/AHA Guidelines. Stanton J Rowe. CEO. NXT Biomedical. I, Stanton Rowe, DO have a financial interest/arrangement . or affiliation with one or more organizations that could be perceived as a real or apparent conflict of interest in the context of the subject of this presentation.. ”. Muhammad Raza, MD, FACC, FSCAI, RPVI.. Interventional cardiologist. Director, Cardiac Cath Lab, . Crozer. Chester Medical Center,. Upland, PA. . Disclosure. Consultant and Proctor – Medtronic. Michael Mack, MD. Baylor Scott & White Health. Dallas, TX. How Have Most Operators and Centers Been Trained in Structural Heart?. 3. Do We Need Formal “Structured” Training in Structural Heart?. Shilpa Shelton, MBA. Program Director, . Bluhm. Cardiovascular Institute. Northwestern Medicine. “Back to the Basics: Coding, Documentation, Coverage”. Disclaimer. The information provided is the experience of the . Nicolas M. Van Mieghem, MD, PhD. For the SURTAVI Trial . Investigators. 0. Disclosure Statement of Financial Interests. Within the past 12 months, I have had a financial interest/arrangement or affiliation with the organization(s) list below. Shinichi Fukuhara, MD . (. 1,4,5). , Stephane Leung, MD (2,4,5), Daizo Tanaka, MD (3,4), Devraj Sukul, MD (1,5), P. . . Michael Grossman, MD (1,5), Stanley J. Chetcuti, MD (1,5), Chang He, PhD (4,5), Melissa Clark, MSN (4,5), Himanshu J. Patel, MD (1,4,5). By: Cole Smith PharmD Candidate 2021. University of Findlay. Preceptor: Katherine Crawford PharmD BCCP. POPular. TAVI Cohort B Trial Review. Background:. TAVI/TAVR- Transcatheter aortic valve implant/replacement. Utilized for patients who have aortic stenosis to help when their valve is not opening correctly. . Evolut. Low Risk Bicuspid Study. Basel Ramlawi, MD, FACC. Valley Health System, Winchester, Virginia. For the . Evolut. Low Risk Bicuspid Investigators. Disclosure Statement of Financial Interests.